Oral antiplatelet agent hypersensitivity and cross-reactivity managed by successful desensitisation

Oral platelet aggregation inhibitors are widely used for the treatment and prevention of cardiovascular diseases, including coronary stent thrombosis. Premature discontinuation following percutaneous coronary intervention would pose a grave risk of in-stent thrombosis, acute myocardial infarction an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Nicholas, Rangamuwa, Kanishka, Mariasoosai, Raymond, Carnes, Jonathan, Thien, Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313754/
https://www.ncbi.nlm.nih.gov/pubmed/25653921
http://dx.doi.org/10.5415/apallergy.2015.5.1.51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313754/
https://www.ncbi.nlm.nih.gov/pubmed/25653921
http://dx.doi.org/10.5415/apallergy.2015.5.1.51

Ejemplares similares